| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |